查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1726135

经导管栓塞和阻塞设备市场规模、份额、趋势分析报告：2025 年至 2030 年按产品、地区和细分市场预测

Transcatheter Embolization And Occlusion Devices Market Size, Share & Trends Analysis Report By Product (Coil, Non-coil),By Region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa), And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 210 Pages | 商品交期: 2-10个工作天内

价格

经导管栓塞和闭塞 (TEO) 设备市场的成长和趋势

根据 Grand View Research, Inc. 的最新报告，全球经导管栓塞和阻塞设备市场预计到 2030 年将达到 85.4 亿美元，2025 年至 2030 年期间的复合年增长率为 7.7%。

TEO 设备市场的主要驱动因素包括微创手术的采用率不断提高和癌症盛行率不断上升。

此外，栓塞术广泛用于治疗非癌症疾病（例如血管畸形和纤维化），正在推动全球对 TEO 设备的需求。此外，技术先进、效率更高的产品的推出也支持了全球市场的成长。然而，高成本、严格的监管核准程序以及需要经验丰富的医疗专业人员来执行 TEO 手术等因素可能会对其发展产生负面影响。

由于医疗保健支出的增加和医疗保健基础设施的改善，亚太地区 TEO 设备市场预计将以最高的复合年增长率成长。亚太新兴国家医疗旅游业的快速扩张也推动了对 TEO 设备的需求。

经导管栓塞及阻塞设备市场报告重点

  • 2024 年，非线圈产品领域占据市场主导地位，收益占有率最大，为 52.3%，这得益于其在广泛临床应用中的多功能性和有效性。
  • 由于线圈产品在各种血管疾病治疗的应用不断扩大，预计预测期内线圈产品部门的复合年增长率将达到 7.0%。
  • 由于介入放射学 (IR) 程序的采用率不断提高，北美在 2024 年占据全球市场主导地位，收益占有率最高，为 36.6%。

目录

第一章调查方法与范围

第二章执行摘要

3. 经导管栓塞和阻塞设备市场变数、趋势和范围

  • 市场体系展望
    • 母市场展望
    • 相关/支持市场展望
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
  • 经导管栓塞及阻塞设备市场分析工具
    • 产业分析—波特五力分析
    • PESTLE分析

第四章。经导管栓塞和阻塞设备市场：按产品进行的估计和趋势分析

  • 产品细分仪表板
  • 经导管栓塞及阻塞设备市场：产品差异分析
  • 全球经导管栓塞及阻塞设备市场规模及趋势分析（依产品，2018-2030）
  • 线圈
    • 可推线圈
    • 可拆卸线圈
  • 无线圈
    • 导流装置
    • 栓塞颗粒
    • 液体栓子
    • 其他栓塞及阻塞设备
    • 配件

5. 经导管栓塞和阻塞设备市场：区域、估计和趋势分析

  • 区域市场仪表板
  • 2024 年及 2030 年区域市场占有率分析
  • 经导管栓塞及阻塞设备市场（按地区）: 关键要点
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 丹麦
    • 瑞典
    • 挪威
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳洲
    • 泰国
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中东和非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第六章 竞争态势

  • 主要市场参与企业的近期趋势和影响分析
  • 公司/竞争对手分类
  • 供应商格局
    • 2024 年重点公司热图分析
  • 公司简介
    • Boston Scientific Corporation
    • Terumo Corporation
    • Medtronic
    • DePuy Synthes（Johnson & Johnson）
    • Stryker
    • Cordis
    • Abbott
    • Pfizer Inc.
    • Sirtex SIR-Spheres Pty Ltd.
    • 诺迪恩（加拿大）公司
Product Code: 978-1-68038-670-7

Transcatheter Embolization And Occlusion Devices Market Growth & Trends:

The global transcatheter embolization and occlusion devices market size is estimated to reach USD 8.54 billion by 2030, registering a CAGR of 7.7% from 2025 to 2030, according to a new report by Grand View Research, Inc. Key drivers of the TEO devices market include increasing adoption of minimally invasive surgeries and rising prevalence of cancer.

In addition, wide usage of embolization technique as a treatment for conditions other than cancer, such as vascular malformations and fibrosis, is fueling the demand for TEO devices globally. Furthermore, introduction of technically advanced products with enhanced efficiency is supporting the global market growth. On the other hand, high cost, stringent regulatory approval procedures, and requirement of experienced healthcare professionals to perform TEO procedures are some of the factors that may have a negative impact on the market development.

Asia Pacific TEO devices market is anticipated to witness highest CAGR, due to increasing healthcare expenditure and improving healthcare infrastructure. Rapid expansion of medical tourism industry in the emerging countries of APAC is also boosting the demand for TEO devices.

Transcatheter Embolization And Occlusion Devices Market Report Highlights:

  • In 2024, The non-coil product segment dominated the market with the largest revenue share of 52.3%, propelled by its versatility and effectiveness in a wide range of clinical applications.
  • Based product, the coil segment is anticipated to grow at a significant CAGR of 7.0% over the forecast period, driven by its growing application in treating various vascular conditions.
  • North America dominated the global market with the largest revenue share of 36.6% in 2024, attributed to the increased adoption of Interventional Radiology (IR) procedures.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Product
    • 1.2.2. Regional Scope
    • 1.2.3. Estimates and Forecasts Timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased Database
    • 1.4.2. GVR's Internal Database
    • 1.4.3. Secondary Sources
    • 1.4.4. Primary Research
    • 1.4.5. Details of Primary Research
  • 1.5. Information or Data Analysis
    • 1.5.1. Data Analysis Models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Product Outlook
    • 2.2.2. Regional Outlook
  • 2.3. Competitive Insights

Chapter 3. Transcatheter Embolization and Occlusion Devices Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
    • 3.2.2. Market Restraint Analysis
  • 3.3. Transcatheter Embolization and Occlusion Devices Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's Five Forces Analysis
      • 3.3.1.1. Supplier Power
      • 3.3.1.2. Buyer Power
      • 3.3.1.3. Substitution Threat
      • 3.3.1.4. Threat of New Entrant
      • 3.3.1.5. Competitive Rivalry
    • 3.3.2. PESTLE Analysis
      • 3.3.2.1. Political Landscape
      • 3.3.2.2. Technological Landscape
      • 3.3.2.3. Economic Landscape

Chapter 4. Transcatheter Embolization and Occlusion Devices Market: Product Estimates & Trend Analysis

  • 4.1. Product Segment Dashboard
  • 4.2. Transcatheter Embolization and Occlusion Devices Market: Product Movement Analysis
  • 4.3. Global Transcatheter Embolization and Occlusion Devices Market Size & Trend Analysis, By Product, 2018 to 2030 (USD Million)
  • 4.4. Coil
    • 4.4.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 4.4.2. Pushable Coils
      • 4.4.2.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 4.4.3. Detachable Coils
      • 4.4.3.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 4.5. Non Coil
    • 4.5.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 4.5.2. Flow Diverting Devices
      • 4.5.2.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 4.5.3. Embolization Particles
      • 4.5.3.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 4.5.4. Liquid Embolics
      • 4.5.4.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 4.5.5. Other Embolization and Occlusion Devices
      • 4.5.5.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 4.5.6. Accessories
      • 4.5.6.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)

Chapter 5. Transcatheter Embolization and Occlusion Devices Market: Regional Estimates & Trend Analysis

  • 5.1. Regional Market Dashboard
  • 5.2. Regional Market Share Analysis, 2024 & 2030
  • 5.3. Transcatheter Embolization and Occlusion Devices Market by Region: Key Takeaways
  • 5.4. North America
    • 5.4.1. U.S.
      • 5.4.1.1. Key Country Dynamics
      • 5.4.1.2. Regulatory Framework/ Reimbursement Structure
      • 5.4.1.3. Competitive Scenario
      • 5.4.1.4. U.S. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 5.4.2. Canada
      • 5.4.2.1. Key Country Dynamics
      • 5.4.2.2. Regulatory Framework/ Reimbursement Structure
      • 5.4.2.3. Competitive Scenario
      • 5.4.2.4. Canada Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 5.4.3. Mexico
      • 5.4.3.1. Key Country Dynamics
      • 5.4.3.2. Regulatory Framework/ Reimbursement Structure
      • 5.4.3.3. Competitive Scenario
      • 5.4.3.4. Mexico Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 5.5. Europe
    • 5.5.1. U.K.
      • 5.5.1.1. Key Country Dynamics
      • 5.5.1.2. Regulatory Framework/ Reimbursement Structure
      • 5.5.1.3. Competitive Scenario
      • 5.5.1.4. U.K. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 5.5.2. Germany
      • 5.5.2.1. Key Country Dynamics
      • 5.5.2.2. Regulatory Framework/ Reimbursement Structure
      • 5.5.2.3. Competitive Scenario
      • 5.5.2.4. Germany Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 5.5.3. France
      • 5.5.3.1. Key Country Dynamics
      • 5.5.3.2. Regulatory Framework/ Reimbursement Structure
      • 5.5.3.3. Competitive Scenario
      • 5.5.3.4. France Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 5.5.4. Italy
      • 5.5.4.1. Key Country Dynamics
      • 5.5.4.2. Regulatory Framework/ Reimbursement Structure
      • 5.5.4.3. Competitive Scenario
      • 5.5.4.4. Italy Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 5.5.5. Spain
      • 5.5.5.1. Key Country Dynamics
      • 5.5.5.2. Regulatory Framework/ Reimbursement Structure
      • 5.5.5.3. Competitive Scenario
      • 5.5.5.4. Spain Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 5.5.6. Denmark
      • 5.5.6.1. Key Country Dynamics
      • 5.5.6.2. Regulatory Framework/ Reimbursement Structure
      • 5.5.6.3. Competitive Scenario
      • 5.5.6.4. Denmark Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 5.5.7. Sweden
      • 5.5.7.1. Key Country Dynamics
      • 5.5.7.2. Regulatory Framework/ Reimbursement Structure
      • 5.5.7.3. Competitive Scenario
      • 5.5.7.4. Sweden Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 5.5.8. Norway
      • 5.5.8.1. Key Country Dynamics
      • 5.5.8.2. Regulatory Framework/ Reimbursement Structure
      • 5.5.8.3. Competitive Scenario
      • 5.5.8.4. Norway Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 5.6. Asia Pacific
    • 5.6.1. China
      • 5.6.1.1. Key Country Dynamics
      • 5.6.1.2. Regulatory Framework/ Reimbursement Structure
      • 5.6.1.3. Competitive Scenario
      • 5.6.1.4. China Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 5.6.2. Japan
      • 5.6.2.1. Key Country Dynamics
      • 5.6.2.2. Regulatory Framework/ Reimbursement Structure
      • 5.6.2.3. Competitive Scenario
      • 5.6.2.4. Japan Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 5.6.3. India
      • 5.6.3.1. Key Country Dynamics
      • 5.6.3.2. Regulatory Framework/ Reimbursement Structure
      • 5.6.3.3. Competitive Scenario
      • 5.6.3.4. India Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 5.6.4. South Korea
      • 5.6.4.1. Key Country Dynamics
      • 5.6.4.2. Regulatory Framework/ Reimbursement Structure
      • 5.6.4.3. Competitive Scenario
      • 5.6.4.4. South Korea Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 5.6.5. Australia
      • 5.6.5.1. Key Country Dynamics
      • 5.6.5.2. Regulatory Framework/ Reimbursement Structure
      • 5.6.5.3. Competitive Scenario
      • 5.6.5.4. Australia Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 5.6.6. Thailand
      • 5.6.6.1. Key Country Dynamics
      • 5.6.6.2. Regulatory Framework/ Reimbursement Structure
      • 5.6.6.3. Competitive Scenario
      • 5.6.6.4. Thailand Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 5.7. Latin America
    • 5.7.1. Latin America Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 5.7.2. Brazil
      • 5.7.2.1. Key Country Dynamics
      • 5.7.2.2. Regulatory Framework/ Reimbursement Structure
      • 5.7.2.3. Competitive Scenario
      • 5.7.2.4. Brazil Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 5.7.3. Argentina
      • 5.7.3.1. Key Country Dynamics
      • 5.7.3.2. Regulatory Framework/ Reimbursement Structure
      • 5.7.3.3. Competitive Scenario
      • 5.7.3.4. Argentina Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 5.8. Middle East and Africa
    • 5.8.1. Middle East and Africa Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 5.8.2. South Africa
      • 5.8.2.1. Key Country Dynamics
      • 5.8.2.2. Regulatory Framework/ Reimbursement Structure
      • 5.8.2.3. Competitive Scenario
      • 5.8.2.4. South Africa Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 5.8.3. Saudi Arabia
      • 5.8.3.1. Key Country Dynamics
      • 5.8.3.2. Regulatory Framework/ Reimbursement Structure
      • 5.8.3.3. Competitive Scenario
      • 5.8.3.4. Saudi Arabia Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 5.8.4. UAE
      • 5.8.4.1. Key Country Dynamics
      • 5.8.4.2. Regulatory Framework/ Reimbursement Structure
      • 5.8.4.3. Competitive Scenario
      • 5.8.4.4. UAE Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 5.8.5. Kuwait
      • 5.8.5.1. Key Country Dynamics
      • 5.8.5.2. Regulatory Framework/ Reimbursement Structure
      • 5.8.5.3. Competitive Scenario
      • 5.8.5.4. Kuwait Market Estimates and Forecasts 2018 to 2030 (USD Million)

Chapter 6. Competitive Landscape

  • 6.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 6.2. Company/ Competition Categorization
  • 6.3. Vendor Landscape
    • 6.3.1. Key Company Heat Map Analysis, 2024
  • 6.4. Company Profiles
    • 6.4.1. Boston Scientific Corporation
      • 6.4.1.1. Company Overview
      • 6.4.1.2. Financial Performance
      • 6.4.1.3. Product Benchmarking
      • 6.4.1.4. Strategic Initiatives
    • 6.4.2. Terumo Corporation
      • 6.4.2.1. Company Overview
      • 6.4.2.2. Financial Performance
      • 6.4.2.3. Product Benchmarking
      • 6.4.2.4. Strategic Initiatives
    • 6.4.3. Medtronic
      • 6.4.3.1. Company Overview
      • 6.4.3.2. Financial Performance
      • 6.4.3.3. Product Benchmarking
      • 6.4.3.4. Strategic Initiatives
    • 6.4.4. DePuy Synthes (Johnson & Johnson)
      • 6.4.4.1. Company Overview
      • 6.4.4.2. Financial Performance
      • 6.4.4.3. Product Benchmarking
      • 6.4.4.4. Strategic Initiatives
    • 6.4.5. Stryker
      • 6.4.5.1. Company Overview
      • 6.4.5.2. Financial Performance
      • 6.4.5.3. Product Benchmarking
      • 6.4.5.4. Strategic Initiatives
    • 6.4.6. Cordis
      • 6.4.6.1. Company Overview
      • 6.4.6.2. Financial Performance
      • 6.4.6.3. Product Benchmarking
      • 6.4.6.4. Strategic Initiatives
    • 6.4.7. Abbott
      • 6.4.7.1. Company Overview
      • 6.4.7.2. Financial Performance
      • 6.4.7.3. Product Benchmarking
      • 6.4.7.4. Strategic Initiatives
    • 6.4.8. Pfizer Inc.
      • 6.4.8.1. Company Overview
      • 6.4.8.2. Financial Performance
      • 6.4.8.3. Product Benchmarking
      • 6.4.8.4. Strategic Initiatives
    • 6.4.9. Sirtex SIR-Spheres Pty Ltd.
      • 6.4.9.1. Company Overview
      • 6.4.9.2. Financial Performance
      • 6.4.9.3. Product Benchmarking
      • 6.4.9.4. Strategic Initiatives
    • 6.4.10. Nordion (Canada) Inc.
      • 6.4.10.1. Company Overview
      • 6.4.10.2. Financial Performance
      • 6.4.10.3. Product Benchmarking
      • 6.4.10.4. Strategic Initiatives

List of Tables

  • Table 1. List of Secondary Sources
  • Table 2. List of Abbreviations
  • Table 3. Global Transcatheter Embolization and Occlusion Devices Market, By Region, 2018 - 2030 (USD Million)
  • Table 4. Global Transcatheter Embolization and Occlusion Devices Market, By Product, 2018 - 2030 (USD Million)
  • Table 5. North America Transcatheter Embolization and Occlusion Devices Market, By Country, 2018 - 2030 (USD Million)
  • Table 6. North America Transcatheter Embolization and Occlusion Devices Market, By Product, 2018 - 2030 (USD Million)
  • Table 7. U.S. Transcatheter Embolization and Occlusion Devices Market, By Product, 2018 - 2030 (USD Million)
  • Table 8. Canada Transcatheter Embolization and Occlusion Devices Market, By Product, 2018 - 2030 (USD Million)
  • Table 9. Mexico Transcatheter Embolization and Occlusion Devices Market, By Product, 2018 - 2030 (USD Million)
  • Table 10. Europe Transcatheter Embolization and Occlusion Devices Market, By Country, 2018 - 2030 (USD Million)
  • Table 11. Europe Transcatheter Embolization and Occlusion Devices Market, By Product, 2018 - 2030 (USD Million)
  • Table 12. U.K. Transcatheter Embolization and Occlusion Devices Market, By Product, 2018 - 2030 (USD Million)
  • Table 13. Germany Transcatheter Embolization and Occlusion Devices Market, By Product, 2018 - 2030 (USD Million)
  • Table 14. France Transcatheter Embolization and Occlusion Devices Market, By Product, 2018 - 2030 (USD Million)
  • Table 15. Italy Transcatheter Embolization and Occlusion Devices Market, By Product, 2018 - 2030 (USD Million)
  • Table 16. Spain Transcatheter Embolization and Occlusion Devices Market, By Product, 2018 - 2030 (USD Million)
  • Table 17. Denmark Transcatheter Embolization and Occlusion Devices Market, By Product, 2018 - 2030 (USD Million)
  • Table 18. Sweden Transcatheter Embolization and Occlusion Devices Market, By Product, 2018 - 2030 (USD Million)
  • Table 19. Norway Transcatheter Embolization and Occlusion Devices Market, By Product, 2018 - 2030 (USD Million)
  • Table 20. Asia Pacific Transcatheter Embolization and Occlusion Devices Market, By Country, 2018 - 2030 (USD Million)
  • Table 21. Asia Pacific Transcatheter Embolization and Occlusion Devices Market, By Product, 2018 - 2030 (USD Million)
  • Table 22. China Transcatheter Embolization and Occlusion Devices Market, By Product, 2018 - 2030 (USD Million)
  • Table 23. Japan Transcatheter Embolization and Occlusion Devices Market, By Product, 2018 - 2030 (USD Million)
  • Table 24. India Transcatheter Embolization and Occlusion Devices Market, By Product, 2018 - 2030 (USD Million)
  • Table 25. South Korea Transcatheter Embolization and Occlusion Devices Market, By Product, 2018 - 2030 (USD Million)
  • Table 26. Australia Transcatheter Embolization and Occlusion Devices Market, By Product, 2018 - 2030 (USD Million)
  • Table 27. Thailand Transcatheter Embolization and Occlusion Devices Market, By Product, 2018 - 2030 (USD Million)
  • Table 28. Latin America Transcatheter Embolization and Occlusion Devices Market, By Country, 2018 - 2030 (USD Million)
  • Table 29. Latin America Transcatheter Embolization and Occlusion Devices Market, By Product, 2018 - 2030 (USD Million)
  • Table 30. Brazil Transcatheter Embolization and Occlusion Devices Market, By Product, 2018 - 2030 (USD Million)
  • Table 31. Argentina Transcatheter Embolization and Occlusion Devices Market, By Product, 2018 - 2030 (USD Million)
  • Table 32. Middle East & Africa Transcatheter Embolization and Occlusion Devices Market, By Country, 2018 - 2030 (USD Million)
  • Table 33. Middle East & Africa Transcatheter Embolization and Occlusion Devices Market, By Product, 2018 - 2030 (USD Million)
  • Table 34. South Africa Transcatheter Embolization and Occlusion Devices Market, By Product, 2018 - 2030 (USD Million)
  • Table 35. Saudi Arabia Transcatheter Embolization and Occlusion Devices Market, By Product, 2018 - 2030 (USD Million)
  • Table 36. UAE Transcatheter Embolization and Occlusion Devices Market, By Product, 2018 - 2030 (USD Million)
  • Table 37. Kuwait Transcatheter Embolization and Occlusion Devices Market, By Product, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market Research Process
  • Fig. 2 Data Triangulation Techniques
  • Fig. 3 Primary Research Pattern
  • Fig. 4 Primary Interviews
  • Fig. 5 Market Research Approaches
  • Fig. 6 Value-Chain-Based Sizing & Forecasting
  • Fig. 7 QFD Modeling for Market Share Assessment
  • Fig. 8 Market Formulation & Validation
  • Fig. 9 Transcatheter Embolization and Occlusion Devices Market: Market Outlook
  • Fig. 10 Transcatheter Embolization and Occlusion Devices Competitive Insights
  • Fig. 11 Parent Market Outlook
  • Fig. 12 Related/Ancillary Market Outlook
  • Fig. 13 Penetration and Growth Prospect Mapping
  • Fig. 14 Industry Value Chain Analysis
  • Fig. 15 Transcatheter Embolization and Occlusion Devices Market Driver Impact
  • Fig. 16 Transcatheter Embolization and Occlusion Devices Market Restraint Impact
  • Fig. 17 Transcatheter Embolization and Occlusion Devices Market Strategic Initiatives Analysis
  • Fig. 18 Transcatheter Embolization and Occlusion Devices Market: Product Movement Analysis
  • Fig. 19 Transcatheter Embolization and Occlusion Devices Market: Product Outlook and Key Takeaways
  • Fig. 20 Coil Market Estimates and Forecast, 2018 - 2030 (USD Million)
  • Fig. 21 Pushable Coils Market Estimates and Forecast, 2018 - 2030 (USD Million)
  • Fig. 22 Detachable Coils Market Estimates and Forecast, 2018 - 2030 (USD Million)
  • Fig. 23 Non Coil Market Estimates and Forecast, 2018 - 2030 (USD Million)
  • Fig. 24 Flow Diverting Devices Market Estimates and Forecast, 2018 - 2030 (USD Million)
  • Fig. 25 Embolization Particles Market Estimates and Forecast, 2018 - 2030 (USD Million)
  • Fig. 26 Liquid Embolics Market Estimates and Forecast, 2018 - 2030 (USD Million)
  • Fig. 27 Other Embolization and Occlusion Devices Market Estimates and Forecast, 2018 - 2030 (USD Million)
  • Fig. 28 Accessories Market Estimates and Forecast, 2018 - 2030
  • Fig. 29 Global Transcatheter Embolization and Occlusion Devices Market: Regional Movement Analysis
  • Fig. 30 Global Transcatheter Embolization and Occlusion Devices Market: Regional Outlook and Key Takeaways
  • Fig. 31 North America Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 32 U.S. Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 33 Canada Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 34 Mexico Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 35 Europe Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 36 U.K. Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 37 Germany Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 38 France Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 39 Italy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 40 Spain Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 41 Denmark Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 42 Sweden Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 43 Norway Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 44 Asia Pacific Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 45 China Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 46 Japan Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 47 India Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 48 South Korea Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 49 Australia Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 50 Thailand Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 51 Latin America Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 52 Brazil Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 53 Argentina Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 54 Middle East & Africa Market Estimates and Forecasts, 2018 - 2030
  • Fig. 55 South Africa Market Estimates and Forecasts, 2018 - 2030
  • Fig. 56 Saudi Arabia Market Estimates and Forecasts, 2018 - 2030
  • Fig. 57 UAE Market Estimates and Forecasts, 2018 - 2030
  • Fig. 58 Kuwait Market Estimates and Forecasts, 2018 - 2030